You have 9 free searches left this month | for more free features.

CIN

Showing 1 - 25 of 654

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hypertension Trial in Cincinnati (CIN-107, Matching Placebo)

Completed
  • Hypertension
  • Cincinnati, Ohio
    Medpace Clinical Pharmacology Unit
Aug 12, 2022

Hypertension Trial in Orlando, Tampa (CIN-107)

Completed
  • Hypertension
  • Orlando, Florida
  • +1 more
Jul 20, 2022

Diabetic Gastroparesis Trial in El Paso (CIN-102 Dose 1, CIN-102 Dose 2, Placebo for CIN-102)

Terminated
  • Diabetic Gastroparesis
  • CIN-102 Dose 1
  • +2 more
  • El Paso, Texas
    Research Site
Aug 9, 2021

Primary Aldosteronism, Hyperaldosteronism Trial in United States (CIN-107 2 mg dosing, CIN-107 4 mg dosing, CIN-107 8 mg dosing)

Recruiting
  • Primary Aldosteronism
  • Hyperaldosteronism
  • CIN-107 2 mg dosing
  • +2 more
  • Los Angeles, California
  • +8 more
Jul 18, 2022

Recurrent Human Papillomavirus Type 16 Associated Cancer Trial in Birmingham, Baltimore (HPV 16 TA-CIN)

Not yet recruiting
  • Recurrent Human Papillomavirus Type 16 Associated Cancer
  • HPV 16 TA-CIN
  • Birmingham, Alabama
  • +1 more
Mar 18, 2022

Acute Lymphoblastic Leukemia (ALL) Trial in New Brunswick, Toronto (Bright Ideas - CIN Training)

Recruiting
  • Acute Lymphoblastic Leukemia (ALL)
  • Bright Ideas - CIN Training
  • New Brunswick, New Jersey
  • +1 more
Jul 30, 2022

Cervical Intraepithelial Neoplasia, Cervical Dysplasia Trial in New Haven (9-valent HPV vaccine, Imiquimod)

Active, not recruiting
  • Cervical Intraepithelial Neoplasia
  • Cervical Dysplasia
  • New Haven, Connecticut
    Smilow Cancer Hospital at Yale New Haven
Aug 5, 2022

Hypertension Trial in United States (CIN-107)

Recruiting
  • Hypertension
  • Huntington Park, California
  • +14 more
Jul 14, 2022

Cataract Surgery Trial (Nepafenac Ophthalmic, Dexamethasone Ophthalmic)

Not yet recruiting
  • Cataract Surgery
  • Nepafenac Ophthalmic
  • Dexamethasone Ophthalmic
  • (no location specified)
Apr 9, 2022

After Whole Vaccination Shcedule With Recombination Quadrivalent

Not yet recruiting
  • HPV Infections
  • +6 more
    • (no location specified)
    May 7, 2022

    Magnetic Resonance Imaging Examination Trial in Wenzhou (MRI,SCC-Ag)

    Recruiting
    • Magnetic Resonance Imaging Examination
    • MRI,SCC-Ag
    • Wenzhou, Zhejiang, China
      The 2nd Affiliated Hospital and Yuying Children's Hospital of WM
    Aug 3, 2022

    Cervical Intraepithelial Neoplasia Grade 1, Cervical Intraepithelial Neoplasia Grade 2 Trial in Linz (Trichloroacetic acid 85%

    Completed
    • Cervical Intraepithelial Neoplasia Grade 1
    • Cervical Intraepithelial Neoplasia Grade 2
    • Trichloroacetic acid 85% (TCA)
    • Linz, Austria
      Department of gynaecology, Ordensklinikum Linz Ges.m.b.H, Barmhe
    Mar 29, 2022

    Cardiovascular Diseases Trial in London (Beetroot Juice)

    Active, not recruiting
    • Cardiovascular Diseases
    • Beetroot Juice
    • London, United Kingdom
      William Harvey Research Institute, Barts and The London School o
    Sep 14, 2022

    First-void Urine Samples for Follow-up of Women Treated for

    Recruiting
    • Cervical Cancer
    • Colli-Pee
    • Qvintip
    • Wilrijk, Antwerp, Belgium
      university of Antwerp - centre for the evaluation of vaccination
    Sep 28, 2021

    Gastroparesis Trial in United States (CIN-102 Dose 1, CIN-102 Dose 2, CIN-102 Dose 3)

    Completed
    • Gastroparesis
    • CIN-102 Dose 1
    • +3 more
    • Chula Vista, California
    • +18 more
    Jul 16, 2021

    Cervical Intraepithelial Neoplasia III Trial in Tuebingen (Non-invasive physical plasma)

    Recruiting
    • Cervical Intraepithelial Neoplasia III
    • Non-invasive physical plasma
    • Tuebingen, Germany
      University Hospital Tuebingen, Department of Women's Health
    Jun 22, 2021

    HPV Infections, Cervical Cancer, Vulvar Cancer Trial in Hangzhou (9-valent HPV vaccine)

    Recruiting
    • HPV Infections
    • +14 more
    • 9-valent HPV vaccine
    • Hangzhou, China
      Huakun Lv
    Feb 23, 2022

    HPV Infections, Cervical Cancer Stage IIa, Vaginal Cancer Trial in Mianyang (2-doses Group among 9-14 years, 3-doses Group among

    Recruiting
    • HPV Infections
    • +6 more
    • 2-doses Group among 9-14 years
    • +2 more
    • Mianyang, Sichuan, China
      Center for Disease Control and Prevention
    Feb 23, 2022

    Cervical Cancer, CIN2, CIN3 Trial in Westdene (Urine HPV testing, Self-collected cervicovaginal specimen, Provider-collected

    Not yet recruiting
    • Cervical Cancer
    • +2 more
    • Urine HPV testing
    • +2 more
    • Westdene, Johannesburg, South Africa
      Clinical HIV Research Unit Temba Lethu Wing Helen Joseph Hospita
    Jun 15, 2022

    HPV Infection Trial in Vienna (FluBHPVE6E7)

    Recruiting
    • HPV Infection
    • FluBHPVE6E7
    • Vienna, Austria
      Medical University of Vienna
    Sep 23, 2021

    HPV Infections, Cervical Cancer, Vulvar Cancer Trial in Guangxi (Experimental: Experimental: 9-valent Human Papillomavirus

    Completed
    • HPV Infections
    • +14 more
    • Experimental: Experimental: 9-valent Human Papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52, 58)
    • Active Comparator: GARDASIL ®9
    • Guangxi, China
      Guangxi Zhuang Autonomous Region Center for Disease Control and
    May 9, 2022

    Predictive for Cervical Intraepithelial Neoplasia Grade 2

    Active, not recruiting
    • Cervical Intraepithelial Neoplasia Grade 2 (CIN2)
      • Herning, Region Of Central Jutland, Denmark
        Department of Gynecology and Obstetrics, Herning Regional Hospit
      Sep 9, 2021

      Cervical Cancer, Genital Warts Trial (Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine, Matching Placebo)

      Active, not recruiting
      • Cervical Cancer
      • Genital Warts
      • Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine
      • Matching Placebo
      • (no location specified)
      Aug 22, 2022

      Cervical Cancer, Vulvar Cancer, Vaginal Cancer Trial in Yangchun (4-valent HPV Vaccine, 9-valent HPV Vaccine, GARDASIL®)

      Completed
      • Cervical Cancer
      • +13 more
      • 4-valent HPV Vaccine
      • +2 more
      • Yangchun, Guangdong, China
        Yangchun Center For Disease Prevention And Control
      Feb 23, 2022

      Cervical Cancer, Vulvar Cancer, Vaginal Cancer Trial in Rongan County (9-valent Human Papillomavirus (Types 6, 11, 16,

      Recruiting
      • Cervical Cancer
      • +13 more
      • 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula Polymorpha)
      • GARDASIL®
      • Rongan County, Guangxi Zhuang Autonomous Region, China
        Rongan County Center for Disease Control and Prevention
      Feb 20, 2022